Literature DB >> 8985308

The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis.

D J Carr1, T J Rogers, R J Weber.   

Abstract

Since the previous review on the role of opioids in the immune system, numerous investigative teams have contributed to the growing pool of information illustrating the tangible relationship between opioids and immune function, particularly as this association pertains to bacterial and viral pathogens. In addition, the recent cloning of both neural- and immune-derived opioid receptors will ultimately facilitate the identification of molecular events that are responsible for the immunomodulatory effects that are mediated by receptor ligation. Specifically, the administration of opioids in vivo can potentially affect the immune system either through direct interaction with receptors on the effector cells or indirectly, through the ligation of receptors found within the central nervous system. This indirect routing is hypothesized to involve secondary pathways including the hypothalamic pituitary adrenal (HPA) axis and the sympathetic nervous system ultimately resulting in immunomodulation. Consequently, a portion of this review addresses the recent data on leukocyte-derived opioid receptors and the potential immunoregulatory role relative to opiold receptors found within the central nervous system. In addition, recent observations on the effects of opioids and immunocompetence is reviewed from both a molecular and cellular perspective. Finally, the consequence of opioid exposure on the competence of the host immune system to microbial pathogens is summarized.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8985308     DOI: 10.3181/00379727-213-44056

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  24 in total

Review 1.  Induction of metallothionein by stress and its molecular mechanisms.

Authors:  S T Jacob; K Ghoshal; J F Sheridan
Journal:  Gene Expr       Date:  1999

Review 2.  Social support and health: a review of physiological processes potentially underlying links to disease outcomes.

Authors:  Bert N Uchino
Journal:  J Behav Med       Date:  2006-06-07

Review 3.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

4.  Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.

Authors:  Eric M Smith
Journal:  Brain Behav Immun       Date:  2007-09-27       Impact factor: 7.217

Review 5.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

6.  Comparative effects of flurbiprofen and fentanyl on natural killer cell cytotoxicity, lymphocyte subsets and cytokine concentrations in post-surgical intensive care unit patients: prospective, randomized study.

Authors:  Hajime Narahara; Yuji Kadoi; Hiroshi Hinohara; Fumio Kunimoto; Shigeru Saito
Journal:  J Anesth       Date:  2013-03-30       Impact factor: 2.078

7.  Perioperative Narcotic Use and Carpal Tunnel Release: Trends, Risk Factors, and Complications.

Authors:  Trent M Gause; John J Nunnery; Abhinav B Chhabra; Brian C Werner
Journal:  Hand (N Y)       Date:  2018-08-01

8.  Opiates and the development of post-injury complications: a review.

Authors:  Martin G Schwacha
Journal:  Int J Clin Exp Med       Date:  2008-01-20

9.  CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.

Authors:  Nazira El-Hage; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-25       Impact factor: 4.147

10.  Intranasal hydrocodone-acetaminophen abuse induced necrosis of the nasal cavity and pharynx.

Authors:  David Alexander; Keith Alexander; Joseph Valentino
Journal:  Laryngoscope       Date:  2012-09-10       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.